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The fact that Parkinson’s disease (PD) can arise
from numerous genetic mutations suggests a unify-
ing molecular pathology underlying the various
genetic backgrounds. To address this hypothesis,
we took an integrated approach utilizing in vitro dis-
ease modeling and comprehensive transcriptome
profiling to advance our understanding of PD pro-
gression and the concordant downstream signaling
pathways across divergent genetic predisposi-
tions. To model PD in vitro, we generated neurons
harboring disease-causing mutations from patient-
specific, induced pluripotent stem cells (iPSCs). We
observed signs of degeneration in midbrain dopa-
minergic neurons, reflecting the cardinal feature of
PD. Gene expression signatures of PD neurons pro-
vided molecular insights into disease phenotypes
observed in vitro, including oxidative stress vulnera-
bility and altered neuronal activity. Notably, PD neu-
rons show that elevated RBFOX1, a gene previously
linked to neurodevelopmental diseases, underlies
a pattern of alternative RNA-processing associated
with PD-specific phenotypes.
INTRODUCTION
Parkinson’s disease (PD) is caused by the specific and progres-
sive loss of dopaminergic (mDA) neurons in the midbrain sub-
stantia nigra. The degeneration of mDA neurons results in a
deficiency of dopamine in the striatum and neuronal denerva-
tion, giving rise to movement-related disorders and cognitive
problems (Shulman et al., 2011). It is recognized that PD is a
complex, age-related disease that results from a mixture of ge-
netic predisposition and environmental factors. There are aCell
This is an open access article unddozen genes identified associated with familial PD cases.
Among the most important genetic influences, mutations in
SNCA and LRRK2 are inherited in an autosomal dominant
pattern (Paisa´n-Ruı´z et al., 2004; Polymeropoulos et al., 1997;
Zimprich et al., 2004), while mutations in PARKIN, DJ-1, and
PINK1 are inherited in an autosomal recessive pattern (Bonifati
et al., 2003; Kitada et al., 1998; Valente et al., 2004). Intrigu-
ingly, although there are a number of definitive genetic muta-
tions identified in familial PD, the mechanisms underlying
progressive neurodegeneration due to these mutations remain
unclear. The fact that different genetic mutations contribute
to a similar spectrum of clinical features and that selective
mDA neuronal degeneration implicates the involvement of
similar downstream signaling pathways across divergent
genetic predispositions.
Recent advances have been made in recapitulating PD-
related phenotypes by directed differentiation of patient-specific
induced pluripotent stem cells (iPSCs) (Byers et al., 2011;
Cooper et al., 2012; Devine et al., 2011; Imaizumi et al., 2012;
Liu et al., 2012; Nguyen et al., 2011; Reinhardt et al., 2013; Sa´n-
chez-Dane´s et al., 2012; Seibler et al., 2011). These human dis-
ease models produced PD phenotypes, including increased
sensitivity to oxidative stress (Byers et al., 2011; Nguyen et al.,
2011) and mitochondrial deficits (Cooper et al., 2012). Neverthe-
less, each of these studies focused on the dysfunction caused by
a single mutation and failed to investigate the common down-
stream pathways that contribute to PD pathogenic mechanisms.
Moreover, strong evidence indicates that not only the genetic
variants but also the pre- and post-transcriptional regulatory
mechanisms are involved in PD pathogenesis.
We report here a combination of iPSC-based disease
modeling of PD with comprehensive transcriptome analysis to
interrogate the common molecular features underlying the early
stages of mDA neuron degeneration. This work reveals dysregu-
lated signaling networks and dynamic splicing alterations, thus
providing mechanistic insights into the development and pro-
gression of PD.Reports 15, 2411–2426, June 14, 2016 ª 2016 The Author(s). 2411
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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RESULTS
Differentiation of Midbrain Dopaminergic Neurons from
Human iPSCs
We recruited a total of 12 iPSC lines in this study (Table S1): three
lines (GM23280, GM23279, and IR1.7) derived from healthy indi-
viduals; six lines carrying heterozygous or homozygous G2019S
mutation in LRRK2 (ND40597, ND40599, ND41181, ND41180
heterozygotes and ND40018, ND35367 homozygotes); one line
with SNCA triplication (ND34391); one line with c.255delA muta-
tion inPARKIN (ND38477); andonesporadiccase (ND39896) (see
Table S2 for patient details). Among these cell lines, three wild-
type (WT) cell lines and three PD cell lines (ND38477, ND35367,
and ND34391) carrying different PD genetic mutations were em-
ployed for the phenotypic characterization and RNA-sequencing
(RNA-seq). The additional PD cell lineswere employed alongwith
the original cell lines to validate the main phenotypic and tran-
scriptome findings. Point mutations in PARKIN and LRRK2
were confirmed by sequencing (Figures S1A and S1B), and
SNCA copy number was verified by qPCR analysis of genomic
DNA (Figure S1C). Immunostaining demonstrated that all
iPSC lines expressed the pluripotent markers NANOG, OCT4,
SSEA4, and TRA1-60 (Figure S1D), and all had apparently normal
karyotypes (Figure S1E). Non-specific in vitro differentiation
demonstrated that the iPSC lines were capable of generating all
three germ layers (Figure S1F). Enriched populations of neural
progenitor cells (NPCs) were derived from WT and PD iPSCs
within 7 days by treating monolayer cultures with the small
molecule inhibitors CHIR99021, SB431542, and Compound E
to modulate key signaling pathways (Li et al., 2011) (Figures 1A
and S2A). qRT-PCR at different time points during differentiation
showed reducedexpressionbyof pluripotencymarkers,whereas
the neuroectoderm makers NESTIN, PAX6, and VIMENTIN were
upregulated (Figure S2B). NPCs were immunopositive for the
neural markers, but not for pluripotency marker (Figure S2C).
Subsequently, NPCs were cultured in the presence of bFGF
and EGF supplemented with reduced dosage of CHIR99021
and SB431542 (Li et al., 2011) for more than ten passages with
persistent expression of neural stem cell markers (Figure S2D).
Since PD is defined pathologically by progressive degenera-
tion of mDA neurons, NPCs were subsequently differentiatedFigure 1. Characterization of mDAs Generated from NPCs
(A) Schematic representation of the mDA differentiation protocol: NPCs were gen
7 days; NPCs were maintained in growth medium supplemented with growth fac
with FGF8b and purmorphamine for 14 days; FP progenitors were further differe
(B) 14 days post-initiation of patterning of NPCs, live cells were stained for the flo
the floor plate marker: FOXA2. Scale bar, 100 mm.
(C) 30 days post-initiation of patterning of NPCs, neurons were stained for the m
200 mm).
(D) Neurons were co-stained for the mature neuronal markers SYP, PSD95 (scale
(E) Expression of pan-neuronal marker TUJ1 and DA neuron markers TH in iPSC
(F) qRT-PCR analysis showing the expression of neuron markers: TUJ1,MAP2, S
mean ± SEM (n = 3).
(G) Quantification of mDA differentiation efficacy based on TH and TUJ1 colocaliz
SEM (n = 3).
(H) Electrophysiological recordings of spontaneous action potentials from WT
neuromodulators applied to WT and PD mDA neurons. APV, an NMDA antagoni
See also Figure S2.into this neuronal type with a combination of patterning and
maturation factors with modifications of published methods
(Doi et al., 2014; Kriks et al., 2011; Li et al., 2011) (Figure 1A).
Exposure to FGF8 and purmorphamine (days 0–14) drove the
NPCs toward midbrain floor plate progenitors, as indicated by
expression of CORIN and FOXA2 (Figure 1B). Quantification of
CORIN-positive population by fluorescence-activated cell sort-
ing was performed in both WT and PD cell lines at day 16 after
differentiation showing yields of 4060% mDA precursors (Fig-
ure S2E). Further maturation was facilitated by g-secretase
inhibitor DAPT plus neurotropic factors glial cell line-derived
neurotrophic factor (GDNF) and BDNF for 14–16 days. Neurons
generated carried the characteristics of DA neurons regionally
specific in substantia nigra pars compacta as indicated by
expression of dopamine active transporter (DAT), G-protein-
activated inward rectifier potassium channel 2 (KIR3.2), vesicular
monoamine transporter 2 (VMAT2), and floor plate marker
FOXA2 (Figure 1C). Confirming their regional identity, the neu-
rons were co-stained for midbrain transcription factors PITX3
and NURR1 (Figure 1D). The mDA neurons also expressed
mature neuronal markers synaptophysin (SYP) and postsynaptic
density protein 95 (PSD95) (Figure 1D). qRT-PCR analysis
further illustrated the upregulation of neuronal markers: TUJ1,
MAP2, SYP, and mDA-specific markers: TH, NURR1, EN1, and
FOXA2 (Figure 1F). To assess the robustness of the differentia-
tion protocol, emerging mDA neurons from both WT and PD
cell lines were characterized for co-expression of the pan-
neuronal marker TUJ1 and DA neuronal marker TH (Figures 1E
and S2G) and the expression of FOXA2 (Figure S2F). Approxi-
mately half of the differentiated neurons were TH+ (Figures 1G
and S2H). The efficacy of mDA differentiation showed no signif-
icant difference between WT and PD cell lines.
We next performed functional studies to investigate the func-
tional properties of these neurons. First, release of dopamine
was confirmed by ELISA (Figure S2I). Second, spontaneous ac-
tion potentials were recorded in a 256-channel microelectrode
array (MEA), indicating that the mDAs neurons were electrically
active (Figure 1H). Furthermore, channel properties expected
of mDA neurons were validated by introducing pharmacological
agents. DL-2-amino-5-phosphonovaleric acid (APV), a selective
NMDA receptor antagonist, significantly reduced the firing rates.erated by introducing small molecule inhibitors into monolayer iPSC culture for
tors for further passaging; NPCs were patterned into ventral midbrain lineage
ntiated into mature neurons with DAPT, GDNF, and BDNF.
or plate surface marker: CORIN. Scale bar, 200 mm; fixed cells were stained for
DA marker DAT, KIR3.2, FOXA2 (scale bar, 100 mm) and VMAT2 (scale bar,
bar, 200 mm) and mDA neuronal markers NURR1, PITX3 (scale bar, 100 mm).
-derived 35-day neurons by immunostaining. Scale bar, 200 mm.
YP, and mDA-specific markers: TH, NURR1, EN1, and FOXA2. Data represent
ation, in 30-day neurons derived fromWT and PD lines. Data represent mean ±
and PD mDA neuron cultures by microelectrode arrays (MEAs); effects of
st; Risperidone, dopamine D2 receptor antagonist.
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Decreased firing was also induced by risperidone, indicating that
the differentiated neurons possessed functional dopamine (DA)-
D2 receptors (Figure 1I). Thus, the in vitro generated mDA neu-
ronswere functional in terms of synthesizing and releasing dopa-
mine, emitting spontaneous synaptic activities, and responding
appropriately to pharmacological blockade.
mDA Neurons Derived from PD iPSCs Exhibit Disease-
Related Phenotypes
Previously, a progressive degenerative phenotype in NPCs was
reported for a LRRK2 iPSC model of PD, which recapitulated
aging-associated molecular processes in vivo (Liu et al., 2012).
Aberrant nuclear architecture was observed upon prolonged
passaging, and late-passage NPCs showed deficiency in prolif-
eration and ability to generate mature neurons. Consistent with
this report, we found that the mDA neurons derived from late-
passage PD NPCs (P12) exhibited morphological abnormality
in neurite length. Cultures of mDA neurons derived from three
WT cell lines and three PD cell lines were co-stained with TUJ1
and TH to visualize the neurite morphology (Figure 2A). Quantifi-
cation of neurite length showed significant (p < 0.001) reduction
in the extension of mDA neurites in ND35367 and ND34391
cell lines (Figure 2B). Noticeably, mDA neurons derived from
ND35367 (LRRK2 G2019S) displayed damaged neurites as
indicated by blebbing in neuronal projections and axonal frag-
mentation. These morphological signs of neurodegeneration
were not observed in WT mDA neurons (Figure 2C). Next, it
was determined that PDmDA neuron cultures showed increased
apoptosis. At day 28, subtle increases of caspase-3 expression
were detected by qPCR in both WT and PD mDA neurons
compared to NPC stage (Figure 2D). However, after further
culturing (day 49), caspase-3 expression was significantly (p <
0.001) elevated in all three PD cell lines (Figure 2D). To further
assess the amount of apoptosis within the cultures at initial
stages, neurons at day 40 were co-stained for MAP2 and
cleaved caspase-3. PD cultures showed significantly higher
percentage of cells that were positive for cleaved caspase-3,
and also showed fragmented neuronal structures and formation
of apoptotic bodies (Figures 2E and 2F). Thus, our results indi-
cate that PD mDA neurons in culture display degenerative
morphologies and undergo apoptosis.
Another clinical feature implicated in PD is the abnormal accu-
mulation of a-synuclein in protein aggregates within Lewy bodies
(Baba et al., 1998; Chung et al., 2001; Farrer et al., 2001; Kalia
et al., 2015). First, SNCAmRNA expression changes were deter-Figure 2. Neurite Shortening in mDAs Derived from PD iPSC Lines
(A) Representative images of neurites double labeled with TUJ1 and TH at day 4
present in mDA cultures derived from iPSCs with LRRK2 G2019S mutation (ND3
(B) Quantification TH+ neurites in mDA cultures from wild-type (WT) and PD cel
Comparisons are by one-way ANOVA followed by Dunnett’s test.
(C) Representative images of loss of neuronal projections particularly in LRRK2 G
(D) Caspase-3 gene expression was detected by qRT-PCR on mDA neuron cu
Comparisons are by two-way ANOVA followed by Bonferroni posttests. ns, non
(E) Immunofluorescence analysis of mDA neurons differentiated from WT and PD
100 mm.
(F) Quantitative analyses of the percentage of neurons with positive staining for cle
way ANOVA followed by Dunnett’s test. *p < 0.05.mined by qPCR with further prolonged culture of mDA neurons
at days 28, 35, 42, and 49 (Figure 3A). Two-way ANOVA tests
were performed to verify the progressive increase in SNCA
expression in a few PD cell lines. On the other hand, ND34391,
which carries the SNCA triplication mutation, showed enhanced
SNCA expression at NPC stage (Figure S3A). Accumulation of
a-synuclein protein was further evaluated by detecting phos-
phorylated form of a-synuclein (PS129a-synuclein), the predomi-
nant type within Lewy bodies (Fujiwara et al., 2002; Sato et al.,
2013; Sugeno et al., 2008). Western blots showed that PD
mDA neurons robustly expressed PS129a-synuclein compared
to WT (Figures 3B and 3C), especially in ND34391, which carries
theSNCA triplicationmutation. The solubility of PS129a-synuclein
was further examined by protein fractionation, indicating that
such phosphorylated species were highly enriched in SDS-
soluble fraction from PD mDA neuronal cultures after further
culturing, but not present in WT (Figures S3B and S3C). Protein
lysates collected from WT (GM23280 and GM23279), ND38477
PARKIN, and ND34391 SNCA mDA neurons at day 44 were
treated with calf-intestinal alkaline phosphatase to verify the
presence of phosphorylated a-synuclein (Figure S3D). Overall,
in the cell line with PARKIN c.255delA mutation, an enrichment
of PS129a-synuclein was observed, corresponding to the Lewy
body pathology in Parkin-related early-onset Parkinsonism and
the related iPSC model (Farrer et al., 2001; Imaizumi et al.,
2012). A mild PS129a-synuclein phenotype was present in most
of the LRRK2 G2019S cell lines, whereas ND34391 (SNCA
triplication) from a patient with cognitive impairment/dementia
and diffuse Lewy Body (Table S2) showed significant PS129a-sy-
nuclein accumulation.
Besides morphological and neurochemical phenotypes, elec-
trophysiological differences between PD and WT neurons were
also observed. MEAs with 256 electrodes embedded within a
cell culture well measured field potentials from multiple areas
within mDA neuron cultures. In this experiment, we selected
the ND35367 (LRRK2 G2019S) cell line for examination since it
presented the most pronounced degeneration-related pheno-
types (Figure 2). It was notable that the simultaneous recording
of cultured neurons revealed synchronized firing networks in
WT cultures (indicated by arrow), while such synchronized firing
was not observed in PD mDA neurons with LRRK2 G2019S mu-
tation (Figure 3D). Moreover, quantification of electrical activity
within the mDA neuron cultures indicated that there was signifi-
cant decrease in the number of active channels and their firing
rates in the PD cell line (Figure 3E). These results suggest that0 post-differentiation of NPCs. Axonal degenerative morphology is obviously
5367). Scale bar, 100 mm.
l lines. Data represent mean ± SEM (n = 3). ns, non-significant; ***p < 0.001.
2019S. Arrows indicate noticeable neurite fragmentation. Scale bar, 10 mm.
ltures differentiated for 28 and 49 days. Data represent mean ± SD (n = 4).
significant; *p < 0.05, **p < 0.01, ***p < 0.001.
iPSCs for 40 days, co-stained for MAP2 and cleaved caspase-3. Scale bar,
aved caspase-3. Data represent mean ± SEM (n = 3). Comparisons are by one-
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Figure 3. Abnormal Accumulation of pS129 a-Synuclein Species and Defective Electrical Activity in PD mDA Cultures
(A) SNCA gene expression was detected by qRT-PCR on mDA neuron cultures differentiated for 28, 35, 42, and 49 days. Data represent mean ± SD (n = 4).
Comparisons are by two-way ANOVA followed by Bonferroni posttests. *p < 0.05, **p < 0.01, ***p < 0.001.
(B) Representative western blot illustrating PS129a-synuclein protein abundance inWT and PDmDA neuron cultures with different genetic backgrounds. PSD95, a
mature neuron marker, and total SNCA was plotted to show neuronal abundance and total SNCA expression.
(C) Quantification of PS129a-synuclein protein abundance in two WT cell lines and four PD cell lines from three biological replicates at days 44–46 after NPC
differentiation. Data represent mean ± SEM (n = 3). Comparisons are by one-way ANOVA followed by Dunnett’s test. *p < 0.05, **p < 0.01.
(legend continued on next page)
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PDmDA neurons display electrophysiological impairment analo-
gous to other PD models observed in vivo and in vitro (Bilbao
et al., 2006; Woodard et al., 2014; Yee et al., 2014).
Increased Oxidative Stress Susceptibility in PD mDA
Neurons
It has been suggested in previous reports that exposure to neu-
rotoxins can cause mitochondrial functional impairment and the
release of reactive oxidative species (ROS), leading to a number
of cellular responses including apoptosis and increased risk of
developing PD (Bove´ and Perier, 2012). To explore the cellular
antioxidant capacity, we compared the neurotoxic sensitivity
of mDA neurons derived from the three PD lines harboring
divergent genetic mutations (Figure 4A). Antioxidant compo-
nents in the cell culture were removed, and after 16 hr various
neurotoxins were added individually. First, 6-OHDA (10 mM)
and MG-132 (2 mM) were used to challenge the mDA neurons.
At 24 hr, cells were stained for TUJ1 and TH to visualize the
neuron morphology and to quantify the neurite length (Figures
4B and 4C). The morphology of mDA neurons from WT cell lines
was unaltered, however, in PD neurons exhibited morphological
changes in neurite length after treatment. TH-positive neurite
length was significantly reduced in ND35367 (p < 0.01) and
ND34391 (p < 0.001), while the decrease was not observed in
WT cell lines (Figure 4D). For MG-132 treatment, the neurite
length in PD cell lines also decreased compared to WT
(Figure 4D).
To further measure the differential susceptibility of neurotoxin-
induced cell death, neurons were stained for TUJ1 and cleaved
caspase-3 after treatment (Figures S4A and S4B). WTmDA neu-
rons had no significant increase in cell death after 6-OHDA treat-
ment, while enhanced apoptosis was noted in the mDA neurons
derived from ND35367 and ND34391 (Figure S4A). In MG-132-
treated cells, such apoptotic populations became more pro-
nounced (Figure S4B). The apoptotic neurons were quantified
based upon the cleaved caspase-3 and normalized by the total
number of nuclei in the field, indicating a statistically significant
increase in cell death in ND35367 and ND34391 cell lines
compared with WT (Figure S4C).
The herbicide paraquat has been identified as an environ-
mental factor for PD that leads to destruction of mDA neurons
in humans (McCormack et al., 2002). To test the effect of para-
quat, neurons were treated with paraquat (400 mM for 20 hr)
and subsequently co-stained for TUJ1 and TH (Figure 4E). The
majority of mDA neurons derived from WT cell lines preserved
the morphology of extended neurites with paraquat incubation,
while in mDA neuron cultures derived from PD cell lines,
showed impaired neurites, especially evident for ND35367
(LRRK2 G2019S). It was notable that there were no intact mDA
neurons in cultures generated from ND35367 after paraquat
treatment. Moreover, although PD mDA neurons displayed a
native neurite shortening phenotype indicated in the DMSO(D) Raster plot of spontaneous spiking activity by using 248-channel MEAs at day
presented as vertical bands of spikes network; MEA recordings reveal less sync
(E) Quantitative analysis of the numbers of firing neurons and firing rates was ca
biological replicates. In each biological replicate, multiple field potentials were re
See also Figure S3.control, the defective neurite further deteriorated after paraquat
treatment (Figure S5C). Subsequently, neurons were stained for
NURR1 and cleaved caspase-3 after neurotoxin treatment (Fig-
ure S5A). The apoptotic neurons in the culture showed a statis-
tically significant enhancement in PD cultures based on two-
way ANOVA (Figure S5B).
In summary, these findings demonstrate that neurotoxin
exposure induces a degenerative impact on neurite extensions,
leading to apoptosis of PD mDA neurons, while the WT cell lines
resist the cytotoxicity and display only minor degenerative phe-
notypes. Overall, these observations indicate that PD mDA neu-
rons are prone to the neurotoxin-induced oxidative stress and
apoptosis.
Identifying Transcriptome Dysregulation in PD mDA
Neurons
Having cultured mDA neurons that display salient characteris-
tics of neural degeneration provided a unique opportunity to
explore the molecular changes associated with early events
and progressive stages of PD pathology. To this end, compre-
hensive gene expression profiling was performed on both
NPC and mDA neurons derived from six iPSC lines, including
three WT cell lines and three PD cell lines carrying different
PD genetic mutations (ND38477 PARKIN c.255delA, ND35367
LRRK2 G2019S, ND34391 SNCA triplication) (Figure 5A).
RNA-seq was performed on two biological replicates for each
condition at a depth of 40 million reads per sample. For a
global view of expression differences in WT and PD cell types,
we applied principal component analysis (PCA) (Figure 5B).
NPCs derived from all iPSC lines clustered (PC1) closely
together (Figure 5B, upper left), indicating that, compared to
mDA neuron cultures, the transcriptomes of NPCs were similar
across different cell lines. Furthermore, the subtle variance be-
tween WT and PD samples across two cell stages was captured
based on PC3 with an overlap between a few samples (Fig-
ure 5B, upper right). Since NPCs gave rise to more homoge-
neous population across PD and WT cell lines, such uniformed
cell population largely affects PCA analysis done with both NPC
and mDA samples in terms of isolating the difference between
PD and WT. When NPCs samples were removed from the
PCA analysis, a clear separation between PD and WT mDA neu-
rons was observed in PC2 (Figure 5B, lower). A total of 908
genes were differentially expressed (p < 0.01 and absolute
fold change >2) between PD and WT mDA neurons, of which
511 were protein-coding and 188 were long non-coding RNA
(Figures 5C and S6A). Enrichment for groups of genes related
within biological pathways and biochemical functions, based
on Gene Ontology (GO), was conducted using Consensus-
PathDB (http://cpdb.molgen.mpg.de). Interestingly, functional
implications of the unifying upregulated protein-coding genes
in PD mDA neurons indicated enriched clustering of gene
functions involved in synaptic signaling transmission, providing38 post-differentiation from NPCs. Synchronized networks in WT cultures are
hronized neuron networks in PD DA cultures.
lculated in one WT cell line (GM23279) and one PD cell line (ND35367) in two
corded indicated by N. Data represent mean ± SD.
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molecular evidence of a unifying dysregulated neuronal activity
in PD mDA neurons (Figures 5D and 5E).
To verify the RNA-seq result, independent differentiation was
performed with the original cell lines and six additional PD lines,
which either carried familial mutations or sporadic cases of un-
known genetic causes (Table S1). The recruitment of additional
cell lines in validation increases confidence that such dysregula-
tion could be the unifying regulators for pronounced disease
phenotypes. In total, 12 cell lines were differentiated into mDA
neurons to validate gene expression differences. Based on the
ranking of p values and fold changes, 38 protein-coding genes
and 22 long non-coding RNAs identified from RNA-seq were
selected for further analysis by qRT-PCR. We observed a certain
level of heterogeneity, reflecting the diversity in genetic back-
ground. However, for the majority of selected genes, the differ-
ential expression was confirmed in a consistent pattern in most
of the PD cell lines (Figure 6A).
RBFOX1 Contributes to Alternative Splicing Events in
PD mDA Neurons Enriched in Mitochondrial-Related
Genes and Neuronal Activity
The RNA-seq data comparing WT and PD neurons represent
a rich resource of information to ascertain molecular changes
associated with the onset and progression of the disease. We
sought to determine how dysregulated gene expression might
contribute to the pathologies observed for PD mDA neurons.
Among the most consistently upregulated genes in PD neurons
was RBFOX1 (RNA-binding protein fox-1 homolog), a neuron-
specific splicing factor known to target the binding motif (U)
GCAUG and regulate alternative exon usage (Jin et al., 2003;
Shibata et al., 2000). RBFOX1 regulates neuronal splicing net-
works and hence controls neuronal excitation. Knockout of
RBFOX1 in mice alters the splicing of exons for multiple tran-
scripts affecting neuronal excitation and calcium homeostasis
resulting in neuronal hyperexcitation (Fogel et al., 2012; Gehman
et al., 2011). We found similar expression of RBFOX1 in PD
and WT cell lines at NPC stage, but a robust elevation in PD
mDA neurons (Figures S6B and S7A). Additionally, protein levels
of RBFOX1 correlated with the disease-related phenotypes
(Figure S3D).
To investigate a potential role of RBFOX1 and globally mea-
sure differential alternative splicing events in the PD mDA
neurons, we generated RNA-seq data with longer pair-end
reads for two WT cell lines (GM23280 and IR1.7) and two PD
cell lines (ND35367 and ND40018), which displayed the highest
RBFOX1 expression (Figure S7B). RNA samples were collected
from two biological replicates of each cell line. Reads thatFigure 4. Neurite Degenerative Effect of Neurotoxins on mDA Neuron-
(A) Schematic representation of neurotoxin assay in mDA neuron cultures.
(B and C) Representative images of neurites double labeled with TUJ1 and TH a
Scale bar, 100 mm.
(D) Quantification TH+ neurite length in mDA neuron cultures from WT and PD
Data represent mean ± SEM (n = 3). WT samples were pooled for comparisons w
non-significant; *p < 0.05; **p < 0.01; ***p < 0.001.
(E) Paraquat-induced defective neurites in mDA neurons derived from late-passa
TH at D34 with DMSO or paraquat treatments. Scale bar, 200 mm. Zoom-in imag
See also Figures S4 and S5.mapped to splice junctions were quantified to reveal alternative
splicing events in both WT and PD mDA neurons (Figure 6B):
645 splicing events involving 439 protein-coding genes were
identified (fold change >2 and p value %0.05). Gene ontology
analysis revealed that genes showing significant differential
splicing in PD mDA neurons are robustly associated with mito-
chondrial function, cell apoptosis, and cellular redox meta-
bolism (Figures 6C and 6D). Such dysregulated antioxidant
network by alternative splicing may affect the threshold of
neuronal degeneration triggered by external stimuli, which
serves as a possible explanation of the increased vulnerability
in PD mDA neurons toward oxidative-stress-induced apoptosis
triggered by neurotoxins.
To identify the differentially spliced genes specifically medi-
ated by RBFOX1, the 439 genes were overlapped with predicted
RBFOX1 targets (Gehman et al., 2011; Weyn-Vanhentenryck
et al., 2014), which generated a short list of 41 genes (Figures
6E and S7E). GO analysis showed a significant enrichment in
GO terms related to neuron projection and neuronal activity (Fig-
ure S7F). In summary, the genome-wide identification of alterna-
tive splicing events inmDA neuron cultures enabled us to identify
the splicing variants in PD mDA neurons associated with differ-
ential expression of RBFOX1.
Dysregulated Splicing Events Mediated by RBFOX1 in
PD mDA Neurons Highlight Disturbed Neuronal Activity
Given the potential importance of dysregulated alternative
splicing in PD (Dredge et al., 2001), two genes previously iden-
tified as under the influence of RBFOX1 were studied in our
in vitro model (Gehman et al., 2011). GRIN1 belongs to the
glutamate receptor channel superfamily that forms functional
heterotetramers with other NMDA receptor gene families.
Two (U)GCAUG motifs within GRIN1 mediate exon 5 inclusion
by RBFOX1 (Figure 7A). The alternative splicing events in
GRIN1 was evaluated by isoform-specific RT-PCR (Figure 7B).
Total GRIN1 transcripts were detected with primers spanning
exons 3 and 4, which are present in all splice variants. The
overall expression of GRIN1 did not vary between PD and
WT mDA neurons. Another isoform with exon 21 inclusion
also did not show much difference and thus serves as a useful
endogenous control. In contrast, the expression of a specific
isoform with exon 5 inclusion showed significant increase in
PD mDA neurons, demonstrating that differential splicing
events in PD mDA neurons are regulated by RBFOX1 (Figures
7B and S7C).
Another gene that showed significantly altered isoform
expression is the known RBFOX1 target gene SNAP25Derived PD iPSCs
t D34 with DMSO control or 6-OHDA treatment (B) and MG-132 treatment (C).
cell lines with 6-OHDA or MG-132 treatment, normalized to DMSO control.
ith individual PD cell lines by one-way ANOVA followed by Dunnett’s test. ns,
ge PD NPCs. Representative images of neurites double labeled with TUJ1 and
es presenting local fields of mDA morphology. Scale bar, 100 mm.
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(Figure S5E). SNAP-25 (synaptosomal-associated protein of
25 kDa) is a component of the SNARE (Soluble NSF Attachment
protein REceptor) complex, interacting with syntaxin and synap-
tobrevin to facilitate neurotransmitter exocytosis. It was notable
that RBFOX1 binding motifs have been spotted in this mutually
exclusive exon pair, resulting in two isoforms, SNAP-25a and b
(Figure 7C). From our RNA-seq data, a differential distribution
of reads in exon 5a and b was observed in WT and PD mDA
neurons (Figure S7D). Further verification was performed in
additional PD cell lines, indicating a consistent dysregulation of
SNAP-25 alternative splicing in PD mDA neurons (Figure 7D).
To further prove that RBFOX1 is the regulator of such alternative
splicing events, short hairpin RNA (shRNA) knockdown of
RBFOX1 was performed in mDA neurons from three WT and
three PD cell lines (ND35367, ND35391, and ND41181). The ef-
ficiency of RBFOX1 knockdown was determined by qRT-PCR,
showing approximately 70% reduction of mRNA expression in
bothWT andPDmDAneuron cultures (Figure 7E). Subsequently,
the splicing events of SNAP-25with either scrambled shRNAs or
RBFOX1 shRNAs transduction were measured. The expression
profiling of SNAP-25 isoforms in PD mDA neurons with RBFOX1
knockdown indicated marked shifts of SNAP-25b expression
(Figure 7F). Thus, we validated the dysregulated RBFOX1-
depenent splicing events in PD mDA neurons. Consistent with
the phenotypic characterization and what we validated in
RBFOX1 downstream splicing targets, a splicing-regulatory
network for controlling neuronal activity was apparent, implying
substantial importance of dysregulated splicing events in our
in vitro model of PD.
DISCUSSION
In this report, we highlight that mDA neurons generated from
PD-specific iPSC lines display disease-like characteristics
in vitro. It is noteworthy that a consistent vulnerability was
observed in different PD cell lines in response to neurotoxin
treatments, indicating enhanced vulnerability to stress in
PD mDA neurons compared to WT. It should be noted that
there was heterogeneity among different PD cell lines.
For example, ND38477 cell line, which carried PARKIN
c.255delA mutation, showed only mild degenerative pheno-
types compared to other cell lines. Such phenotypic diversity
in vitro is unsurprising given the complex nature of PD pro-
gression associated with various genotypes and the underly-
ing individual-to-individual genome variation, which manifests
in patients as a broad time frame of disease initiation and
development.Figure 5. Global Gene Expression in NPCs and mDA Neurons Derived
(A) Schematic diagram of RNA-seq experimental design and analysis workflow.
(B) Principal component analysis (PCA) illustrating clustering of cell types based o
based on the PC3. After removing the NPC samples, PCA shows the separation o
replicates was observed in PC1.
(C) Transcriptome characterization by DESeq analysis identifies 908 differentially
upregulated and downregulated classes.
(D) Gene ontology analysis of upregulated genes in mDA neuron cultures derived
(E) Heatmap depiction of the representative differentially expressed genes within
See also Figure S6.To date, only a few studies on transcriptome profiling of
iPSC-derived neurons have been discussed in the context of
neurodegenerative diseases. Among these studies, researchers
interrogated the alterations in monogenic PD (Reinhardt et al.,
2013; Woodard et al., 2014). However, the phenotypic similarity
of neuronal degeneration across PD genetic mutations firmly
implies the sharing of common downstream signaling path-
ways. Toward this end, a collection of iPSC lines with distinct
PD mutations were recruited for gene expression profiling to
identify molecular regulators that could be potentially important
for early events in PD progression. Although the reprogram-
ming procedures have become more efficient and standard in
recent years, it has been observed that iPSCs generated
from different sources or even same starting cell population
yield variable epigenetic signatures (Bar-Nur et al., 2011; Lister
et al., 2011). Thus, some gene expression differences we
observed might be due to the genome variance in two-group
comparison. In order to minimize the impact of inconsistent
iPSC identities, larger numbers of iPSC cohorts for each type
of genetic mutations and healthy individuals would need to
be recruited, including multiple clones from the same patient.
Another means to minimize genetic heterogeneity in patient
samples is to generate isogenic iPSC lines using gene-editing
technologies.
Intriguingly, we observed a consistent pattern of gene dysre-
gulation in PD mDA neurons across different gene mutations.
A key neuron-specific splicing factor RBFOX1 was found
consistently over-represented in PD mDA neurons. RBFOX1
has been linked to various neurological disorders including
epilepsy, mental retardation, and autism spectrum disorder
(Bhalla et al., 2004; Martin et al., 2007; Voineagu et al., 2011;
Wen et al., 2015), revealing an important role of alternative
splicing events in regulating the homeostasis of neuronal func-
tion. Thus, the splicing dysregulation triggered by RBFOX1 in
PD progression was further evaluated by RNA-seq. Notably,
the abnormal splicing events in NMDA receptor GRIN1 and
SNARE component SNAP-25 due to overrepresentation of
RBFOX1 in PD mDA neurons provide apparently important
clues to the decreased neuronal activity described in our
cell-culture model. The alternative splicing of exon 5 in GRIN1
substantially contributes to the GRIN1 receptor activity (Vance
et al., 2012). NMDA receptors consisting of GRIN1 subunits
that contain exon 5 possess lower potency of NMDA receptor
agonists and displays faster deactivation (Paoletti et al.,
2013; Rumbaugh et al., 2000). Thus, the increase expression
of exon-5-containing GRIN1 due to overrepresentation of
RBFOX1 in PD mDA neurons could possibly explain thefrom WT and PD iPSCs by RNA-sequencing
Two biological replicates were sequenced in each condition.
n the first principal component (PC1) and the separation of PD andWT samples
f PD and WT mDA samples in PC2, and a subtle batch effect of two biological
expressed transcripts in PDmDA neurons. Separate pie charts were plotted for
from PD iPSC lines compared with WT.
gene ontology categories presented in Figure 5D.
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decreased neuronal firing rates that we observed by MEA
recording. Alternative splicing of exon 5a or 5b in SNAP-25
introduces nine amino acid substitutions in the C-terminal end
of the first SNARE motif and the first part of the cysteine-con-
taining linker (Nagy et al., 2005). The characteristics of exocy-
tosis with different SNAP-25 isoforms have been evaluated,
varying in their ability to stabilize vesicles in the releasable
pools (Sørensen et al., 2003). A balanced expression of the
two isoforms is required for maintaining an operational neuronal
network homeostasis. One could speculate that such dysregu-
lated splicing events could be the preceding events affecting
the neuron function in PD pathology.
From previous reports and the phenotypic characterization in
our study, there is strong evidence of mitochondria-mediated
oxidative stress implicated in PD mDA neurons (Byers et al.,
2011; Nguyen et al., 2011; Reinhardt et al., 2013; Sa´nchez-
Dane´s et al., 2012). Thus, the evaluation of altered cell responses
to various neurotoxic substances highlights the overall vulnera-
bility of PD mDA neurons toward oxidative stress, reflecting a
proof of concept for the potential PD mechanisms between dys-
regulated mitochondrial splicing and neuronal degeneration.
In short, these findings further validate iPSC-based modeling
of PD with various genetic backgrounds. Moreover, splicing
modulation by RBFOX1 could be induced by depolarization
(Lee et al., 2009). Thereby, the enrichment of specific splice var-
iants in PD mDA neurons could be gradually achieved along
with advancing neurons, which corresponds well to the age
dependence of neurodegenerative processes. Taken together,
the expression profiling of PD iPSC-based model supports our
initial hypothesis that a unifying pattern of molecular changes
has already occurred in the target PD mDA neurons as early
events in disease progression. The differential gene expression
and defective splicing regulation in PD mDA neurons reveals a
complex homeostatic crosstalk between transcriptional regula-
tion and splicing network mediated by neuron-specific splicing
factor RBFOX1. Further elucidation of the factors mediating the
upregulation of RBFOX1, and how RBFOX1 impacts the function
of downstream splicing targets in PD neurons, will have impor-
tant relevance to our understanding of the early pathogenesis
of PD. It will be interesting to test whether the dysregulation
of RBFOX1 in WT cell lines could induce neurodegenerative
phenotypes.
EXPERIMENTAL PROCEDURES
Maintenance and Characterization of Human iPSCs
WT iPSC lines GM23280A andGM23279A, PD iPSC lines ND34391, ND35367,
ND38477, ND40018, ND41181, ND41180, ND40600, ND40597, ND40599, andFigure 6. RNA-Sequencing Identified Global Alternative Splicing Dysre
(A) Selective list of genes showed consistent differential expression in PD cell lines
to controls. Data represent mean ± SD (n = 3); *p < 0.05; **p < 0.01; ***p < 0.001
(B) Scheme of RNA-seq analysis for detecting alternative splicing variants.
(C) Gene ontology analysis of genes with differentially alternative splicing in PD m
(D) Heatmap of normalized read counts at splice junctions of representative PD-
(E) Venn diagram showing the overlap of alternative splicing events in PD versus
using the hypergeometric test.
See also Figure S7.ND39896 were obtained from the Coriell Cell Repositories. WT iPSC line IR1.7
was a kind gift of Dr. Irene Aksoy. For feeder-free culture, cells were cultured
with chemically defined mTeSR medium (STEMCELL Technologies) on Matri-
gel-coated tissue culture plates.
Differentiation of hPSCs into NPCs and mDA Neurons
NPCs were generated using an adapted protocol (Li et al., 2011). NPCs were
regularly cultured in maintenance contained N2B27 medium supplemented
with 3 mM CHIR99021, 2 mM SB431542, 5 mg/ml BSA, 20 ng/ml bFGF, and
20 ng/ml EGF. Differentiation of NPCs into mDA neurons was initiated 1 day
after passaging the NPCs on poly-L-ornithine hydrochloride/laminin-coated
culture. NPC maintenance medium was substituted by mDA patterning
medium consisting of N2B27 medium supplemented with FGF8, Purmorph-
amine, Dibutyryl cAMP (db-cAMP), and L-ascorbic acid (L-AA) for 14 days.
From days 14, cells were fed with maturation medium consisting of GDNF,
BDNF, DAPT, db-cAMP, and L-AA.
Immunofluorescence Microscopy
Cells were fixed in ice-cold 4% paraformaldehyde (PFA) for 25 min and subse-
quently permeabilized by PBS solution with the detergent Tween 20 (PBST)
and blocked with 10% fetal bovine serum in PBST for 30 min. Primary anti-
bodies were diluted in blocking buffer and incubated overnight at 4C. Sec-
ondary antibodies conjugated with Alexa Fluor (Invitrogen) were diluted 1:
500 in blocking buffer and incubated for 45 min at room temperature. DAPI
(0.5 mg/ml) was used to visualize cell nuclei. The respective primary antibodies
and dilutions are provided in Table S5. Image acquisition and processing was
performed in AxioVision software (Zeiss). Confocal images were taken using a
Zeiss LSM 510 upright confocal microscope. Co-localization efficiency for
immunofluorescence of Tuj1 and TH was determined using ImageJ JACoP
plugin based on Pearson’s coefficient of correlation. Neurite length quantifica-
tion was performed by ImageJ NeuronJ plugin.
RNA-Sequencing and Data Analysis
Total RNAs were extracted with Trizol reagent (Invitrogen) and purified
with RNeasy Mini kit (QIAGEN), according to the manufacturers’ instructions.
Ribosomal-RNAs were depleted from 4 mg total RNAs by using Ribo-Zero
Gold rRNA Removal Kit (Human/Mouse/Rat) (Epicenter Illumina), and RNA-
sequencing libraries were constructed by using 20 ng ribosomal RNA
(rRNA)-depleted total RNA samples with NEBNext Ultra RNA Library Prep
Kit for Illumina (New England Biolabs). RNA-sequencing at a 51- or 76-bp
single-end read scale was performed on an Illumina Platform HiSeq2000
(Genome Institute of Singapore), using rRNA-depleted total RNA from two
biological replicates of the WT cell lines GM23280A, GM23279A, and IR1.7
and PD iPSC lines ND34391, ND35367, and ND38477 cell at NPC stage and
mDA stage. Reads were uniformly trimmed down to 51 bp and mapped with
Tophat2 to the human genome version hg19. Reads were counted using R,
normalized reads were obtained using the regularized log transformation.
Differentially expressed genes were identified using DESeq2 (Love et al.,
2014). The PCA plot was calculated on the top 10,000 genes that showed
the highest variance across the samples.
For detecting alternative splicing events, RNA-sequencing libraries were
generated from intact poly(A)+ RNAs prepared by using Oligo d(T)25 Magnetic
Beads (New England Biolabs). RNA-sequencing was conducted on an Illumina
Platform HiSeq2000 at a 101-bp paired-end read scale. Reads were aligned
using the same software and parameters as the other datasets. RNA-seqgulation of Oxidative-Stress-Responsive Genes
. Resultswere plotted as fold differences of relative gene expression normalized
.
DA neurons relative to WT mDA neurons.
specific alternative splicing events in 47 mitochondrial-related genes.
WT with predicted RBFOX1 targets. Significance of the overlap was estimated
Cell Reports 15, 2411–2426, June 14, 2016 2423
Figure 7. Differential Alternative Splicing of GRIN1 and SNAP-25 Mediated by RBFOX1 in PD mDA Neurons
(A) Alternative splice variants in human GRIN1 mainly involved with exon 5 and exon 21. Hatched box below indicated the exon 5. Yellow boxes represent (U)
GCAUG motifs.
(B) Relative expression levels of various GRIN1 isoforms in WT and PD mDA neurons. Data represent mean ± SD (n = 3).
(C) SNAP-25 gene structure: hatched boxes indicate the open reading frame of SNAP-25. Yellow boxes represent (U)GCAUG motifs. Arrows indicate the
locations of primers for detection of different isoforms.
(D) qRT-PCR verified the relative expression levels of SNAP-25a and SNAP-25b in WT and PD mDA neurons normalized to total transcripts of SNAP-25. Data
represent mean ± SD (n = 3). ***p < 0.001.
(E) Knockdown efficiency of RBFOX1 shRNAs was determined by qPCR in WT and PD mDA neurons relative to scramble shRNA controls. WT cell lines and PD
cell lines were pooled for comparisons. Data represent mean ± SD (n = 3).
(F) Relative expression levels of SNAP-25a and SNAP-25b after scramble shRNA knockdown and RBFOX1 knockdown inWT andPDmDA neurons normalized to
total SNAP-25 transcripts. WT cell lines and PD cell lines were pooled for comparisons. Data represent mean ± SD (n = 3). ns, non-significant; *p < 0.05.
See also Figure S7.reads that mapped to two exons (junction reads) were used to quantify splicing
events (Lu et al., 2013). For each gene, DESeq2 was used to identify exon
junctions that significantly differed between WT and PD samples relative to
the total junction read count for that gene.
Statistical Analysis
Statistical analysis was performed using Statistical Package GraphPad
Prism v.5.0c (GraphPad Software). Two-tailed unpaired Student’s2424 Cell Reports 15, 2411–2426, June 14, 2016t test was universally used for the comparison of two groups. Statistical
testing also involved one-way ANOVA with Bonferroni’s multiple com-
parison test or Dunnett’s test for multiple comparisons, as indicated in
the figure legend. Data are expressed as means ± SEM or means ±
SD) as indicated. Significance was considered for *p < 0.05; **p < 0.01;
***p < 0.001.
Additional details are provided in the Supplemental Experimental
Procedures.
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